-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Shannon Herzog, MD candidate1*, Daniel J. Weisdorf, MD2, Ryan Shanley, M.S3*, Margaret L. MacMillan, MD4, Shernan G Holtan, MD1 and Najla El Jurdi, MD5*

1University of Minnesota, Minneapolis, MN
2Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
3Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN
4Blood and Marrow Transplant Program, Department of Pediatrics, University Of Minnesota, Minneapolis, MN
5Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Sameem Abedin, MD1, Mehdi Hamadani, MD1, Shernan G Holtan, MD2, Gary J. Schiller, MD3, Molly Gallogly, MD, PhD4, Edmund K. Waller, MD, PhD5, Satyajit Kosuri, MD6*, Sunil H Abhyankar, MD7, Sarah M. Anand, MD8*, Mahasweta Gooptu, MD9, Iming Cho, PhD10*, Simona Reed, PhD10*, Shih-Yao Lin, MD, PhD10*, Jesse W Hall, MD10* and Paul J Martin, MD11

1The BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
2University of Minnesota, Minneapolis, MN
3David Geffen School of Medicine at UCLA, Los Angeles, CA
4University Hospitals Seidman Cancer Center, Cleveland, OH
5Winship Cancer Institute, Emory University, Atlanta, GA
6University of Chicago Medical Center, Chicago, IL
7University of Kansas Cancer Center, Westwood, KS
8University of Michigan, Ann Arbor, MI
9Dana-Farber Cancer Institute, Boston, MA
10AltruBio Inc, San Francisco, CA
11Fred Hutchinson Cancer Research Center, Seattle, WA

Emmanuelle Godefroy1*, Patrice Chevallier, MD2, Fabienne Haspot, PhD3*, Caroline Vignes, PhD1*, Véronique Daguin3*, Sylvia Lambot1*, Thierry Guillaume, MD, PhD4*, Margaux Verdon1*, Pierre Peterlin, MD5*, Alice Garnier, MD6*, Maxence Mougon1*, Amandine Le Bourgeois, PhD4*, Maxime Jullien, MD7*, Francine Jotereau, PhD1,8* and Frédéric Altare, PhD1*

1INCIT - IRS-2, INSERM UMR 1302, Nantes, France
2Clinical Hematology, Nantes University Hospital, Nantes, France
3CR2TI, INSERM U1064, Nantes, France
4Clinical Hematology Department, Nantes University Hospital, Nantes, France
5Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
6Hematology Department, Nantes University Hospital, Nantes, France
7Clinical Hematology, Nantes University Hospital, NANTES, France
8INCIT - IRS-2, University of Nantes, Nantes, France

Victor Ling Wei Teik, MD, MRCP1*, Yeh Ching Linn, MBBS, MRCP2*, Michelle Limei Poon, MBBS, MRCP3*, Jeffrey Quek, MBBS2*, Lip Kun Tan, MBBS, FRCP, FRCPath1*, Zi Yi Lim, MB ChB4*, Colin Phipps Diong, MB BCh BAO5*, Balamurugan Vellayappan, MBBS6*, Joanne Lee, MBBS7*, William YK Hwang, MBBS2, Hein Than, MD, FRCPath, MRCP2, Aloysius YL Ho, MBBS, FRCP, FRCPath2, Ian Wu, MBBS, MRCP1,8, Yang Liang Boo, MD, MRCP1,9, Teck Guan Soh1*, Gina Gan2*, Yvonne Su Ming Loh, MBBS, MRCP10, Yin Jie Koh1* and Liang Piu Koh, MBBS, MRCP1*

1Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
2Department of Hematology, Singapore General Hospital, Singapore, Singapore
3National University Health System, National University Cancer Institute, Singapore, Singapore
4Center for Clinical Hematology, Mount Elizabeth Novena Medical Center, Singapore, Singapore
5Parkway Cancer Center, Mount Elizabeth Novena Medical Center, Singapore, Singapore
6Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore
7National University Hospital, Singapore, Singapore
8Department of Haematology, Sengkang General Hospital, Singapore, Singapore
9Hematology Unit, Medical Department, Hospital Sultanah Aminah, Johor Bahru, Malaysia
10Curie Oncology, Singapore, Singapore

Eduardo Rodriguez Arbolí, MD1*, Catherine J. Lee, MD2, Teresa Caballero, PhD3*, Clara Garcia-Calderon4*, Carmen Martinez, MD, PhD5*, Maria Aranzazu Bermudez6*, Lucía López Corral, MD PhD7*, Ana Triguero8*, Lynn E. Onstad, ScM9*, Stefanie Sarantopoulos, MD, PhD10, Stephanie J. Lee, MD, MPH9 and Jose A. Perez-Simon, MD, PhD1

1Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
2Utah Blood and Marrow Transplant Program, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
3Department of Hematology, Hospital Universitario Virgen del Rocio; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla,Spain, Sevilla, Spain
4Department of Hematology, University of Seville, Madrid, ESP
5Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clínic, Barcelona, Spain
6Hospital Universitario Marques De Valdecilla, Santander, ESP
7Department of Hematology, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
8Hematology Department, Hospital Clínic, Barcelona, Spain
9Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
10Duke Cancer Institute, Duke University Medical Center, Durham, NC

Yanmin Zhao1,2,3*, Lifan Tu4*, Yishan Ye, MD1,5,6*, Yi Luo, M.D.1,3,7*, Jimin Shi, M.D.1,7,8*, Jian Yu, Ph.D.3,7,8*, Yi Yu, PhD5*, Fankai Meng, PhD9,10*, Tao Wang4* and He Huang3,5,8,11

1Institute of Hematology, Zhejiang University, Hangzhou, China
2Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
4Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing, China
5Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
6Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China
7Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China
8Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou 311121, China, Hangzhou, China
9Tongji Hospital of Tongji Medical college of Huazhong University Science and Technology, Wuhan, China
10Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
11Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Robert Zeiser, MD1, Zhenyi Xue, PhD2*, Valkal Bhatt, PharmD2*, John Galvin, MD, MPH2* and Franco Locatelli, MD3,4

1University Medical Center Freiburg, Freiburg, Germany
2Incyte Corporation, Wilmington, DE
3Catholic University of the Sacred Heart, Rome, Italy
4IRCCS Ospedale "Bambino Gesù", Rome, Italy

Anne-Claire Mamez1*, Amandine Pradier2*, Caroline Stephan3*, Federica Giannotti, MD1*, Stavroula Masouridi-Levrat, MD1*, Sarah Morin1*, Dionysios Neofytos, MD4*, Diem-Lan Vu4*, Astrid Melotti2*, Isabelle Arm-Vernez4*, Christiane S. Eberhardt5*, Jerome Tamburini, MD, PhD2*, Laurent Kaiser4,6,7*, Yves Chalandon, MD1,2 and Federico Simonetta, MD, PhD1,2*

1Department of Hematology, Geneva University Hospitals, Geneva, Switzerland
2Translational Research Center for Oncohematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
3Transfusion Unit, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland
4Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
5Center for Vaccinology, University Hospitals of Geneva and Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva 14, CHE
6Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, Geneva University Hospitals, Geneva, Switzerland
7Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland

Eric Gaskill, PharmD1*, Maya Padilla, PA-C1*, Rawan Faramand, MD1, Aleksandr Lazaryan, MD, PhD, MPH1, Farhad Khimani, MD1, Lia Perez, MD2*, Joseph Pidala, MD, PhD2 and Rebecca Gonzalez, PharmD, BCOP1*

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL

Alessandra Picardi1,2*, Francesca Lorentino, PhD3*, Alessandro Rambaldi, MD4, Benedetto Bruno, MD, PhD5*, Fabio Benedetti, MD6,7*, Michela Cerno8*, Paolo Bernasconi, MD9, William Arcese10*, Pietro Pioltelli, MD11*, Domenico Russo, MD12, Andrea Bacigalupo, MD13, Massimo Martino14,15*, Emanuele Angelucci, MD16, Angelo Michele Carella, MD17*, Francesco Onida, MD18, Attilio Olivieri, MD19*, Anna Maria Raiola20*, Anna Paola Iori, MD21*, Francesca Patriarca, MD, PhD22*, Elena Oldani, MSc23,24*, Fabio Ciceri, MD25* and Francesca Bonifazi, MD26*

1Stem Cell Transplant Program of AORN Cardarelli, Naples, Italy
2Dipartimento di Biomedicina e Prevenzione, Università di Roma Tor Vergata, Rome, Italy
3PhD Program in Public Health, School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy
4Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
5Division of Hematology, Department of Molecular Biotechnology and Health Sciences, AOU Città della Salute e della Scienza di Torino, Turin, Italy
6Hematology and Stem Cell Transplantation, Azienda Ospedaliera Universitaria di Verona, Verona, Italy
7Department of Medicine, Section of Hematology and Bone Marrow Transplant Unit, University of Verona, Verona, Italy
8Clinica Ematologica Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy
9HSCT Unit, UOC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
10Fondazione Policlinico Campus Biomedico, Rome Transplant Network, Rome, Italy
11Ospedale San Gerardo, Clinica Ematologica dell`Universita Milano-Biocca, Monza, MB, Italy
1214Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
13Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universita’ Cattolica del Sacro Cuore, Rome, Italy
14Stem Cell Transplant and Cellular Therapies Unit, "BMM" Hospital, Reggio Calabria, Italy, Reggio Calabria, Italy
15Grande Ospedale Metropolitano BMM- Centro Unico Trapianti A. Neri, Alberto Neri, Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
16Department of Hematology II, Ospedale San Martino, Genoa, Italy
17Ematologia e Centro Trapianto CSE, Fondazione Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
18BMT Center - Hematology Unit, IRCCS Ospedale Maggiore Policlinico Di Milano-University of Milan, Milano, Italy
19Università Politecnica Delle Marche, Ancona, Italy
20Divisione di Ematologia, Policlinico San Martino, IRCCS, Genova, Italy, Genova, Italy
21Dip. Biotecnologie Cellulari ed Ematologia, Univ. La Sapienza, Rome, Italy
22Haematological Clinic and Transplant Centre, University Hospital of Central Friuli, DAME, University of Udine, Udine, Italy
23Haematology Unit, “ASST Papa Giovanni XXIII”, Bergamo, Italy, Bergamo, Italy
24Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
25Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
26IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, NA, Italy

Remy Dulery, MD1*, Florent Malard, MD, PhD1*, Eolia Brissot, MD, PhD1*, Anne Banet, MD2*, Simona Sestili, MD2*, Ramdane Belhocine, MD2*, Martina Calabrò, MD2,3*, Zoé Van De Wyngaert, MD2*, Agnès Bonnin2*, Tounes Ledraa, MD2*, Ollivier Legrand, MD, PhD2*, Myriam Labopin, MD2,4*, Elodie Capderou, MD5*, Ariel Cohen, MD, PhD5*, Stéphane Ederhy, MD5* and Mohamad Mohty, MD PhD6

1Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France
2Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
3Federico II University of Naples, Hematology Department, Naples, Italy, Rome, LA, Italy
4Acute Leukemia Working Party, Paris Study Office, CEREST-TC, European Society for Blood and Marrow Transplantation, Paris, France
5Department of Cardiology, Sorbonne University, UNICO – GRECO cardio oncology Program, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
6EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France

Nahid Rashid, MD1,2, Mukta Arora, MD3, Paul A. Carpenter, MD4, Amin M Alousi, MD5, Betty K. Hamilton, MD6, Joseph Pidala, MD, PhD7, Lynn E. Onstad, ScM4*, Corey Cutler, MD, MPH, FRCPC8, Mary E. D. Flowers, MD1, Sally Arai, MD9, Smita Bhatia, MD, MPH10 and Stephanie J. Lee, MD, MPH4

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Department of Medicine, University of Washington, Seattle, WA
3Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Cleveland Clinic Foundation, Cleveland, OH
7Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
8Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA
9Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA
10Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL

Norbert Hollaender1*, Ekkehard Glimm1*, Jennifer Gauvin2*, Tommaso Stefanelli, MD1* and Robert Zeiser, MD3

1Novartis Pharma AG, Basel, Switzerland
2Novartis Pharmaceuticals Corporation, East Hanover, NJ
3Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany

Enrico Velardi, PhD1*, Sara Flamini, PhD1*, Federica Galaverna, MD, PhD1*, Emilia Boccieri, MD1*, Carmen Dolores De Luca, MD1*, Francesca Benini1*, Francesco Quagliarella2*, Marco Rosichini1*, Marialuigia Catanoso, MD1*, Antonella Cardinale1*, Shirley Velardi, PhD1*, Gabriele Volpe3*, Angela Pitisci1*, Marianna Coccetti3*, Roberto Carta, MD1*, Francesca Del Bufalo, MD1*, Valentina Bertaina4*, Marco Becilli, MD1*, Daria Pagliara, MD, PhD1*, Mattia Algeri, MD5*, Pietro Merli, MD1* and Franco Locatelli, Prof., MD, PhD1,6

1Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
2Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children Hospital (IRCCS), Rome, Italy
3Research Laboratories, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
4Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, RM, Italy
5Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Lazio, Italy
6Catholic University of the Sacred Heart, Rome, Italy

Paul Szabolcs, MD1, Taylor Nee, MS2*, Xiaohua Chen, MD PhD2, Dhivyaa Rajasundaram, PhD3* and Rafic J. Farah, MD4

1Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
2Division of Blood and Marrow Transplantation and Cellular Therapy, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
3Division of Health Informatics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
4UPMC Hillman Cancer Center, Pittsburgh, PA

Di Yao, MM*, Bohan Li, MM*, Lu Liu*, Lijun Meng, PhD*, Shaoyan Hu, MD, PhD and Yuanyuan Tian*

Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Jerrica Tang, PharmD1*, Ryan Jensen, PharmD1*, Baylee Bryan, PharmD1*, Daanish Hoda, MD2 and Bradley Hunter, MD, MPH1

1BMT / Cellular Therapy, Intermountain Healthcare, LDS Hospital, Salt Lake City, UT
2Intermountain Health, LDS Hospital, Salt Lake City, UT

Rohtesh S. Mehta, MD1, Rima M. Saliba, PhD1*, Amin M Alousi, MD1, Gheath Alatrash, PhD, DO2, Qaiser Bashir, MD1, Partow Kebriaei, MD1, Issa F. Khouri, MD1, Yago Nieto, MD3, Betul Oran, MD, MS4, Uday R Popat, MD1, Muzaffar H Qazilbash, MD1, Jeremy L. Ramdial, MD1, Gabriela Rondon, MD5, Samer A Srour, MD, MS6, Katy Rezvani, MD1, Richard E Champlin, MD1, Elizabeth J Shpall, MD1 and Kai Cao, MS, MD7

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
3Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
4Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
7Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Doris Ponce, MD1, Jonathan U Peled, MD, PhD2, Bindu Tejura, MD3,4, Christopher Ford3*, Marcel R M van den Brink, MD, PhD5, Mary Jane Lombardo, PhD3*, Satyajit Kosuri, MD6*, Nandita Khera, MD, MPH7, Zachariah Defilipp, MD8 and Lisa von Moltke, MD3*

1MSKCC, New York, NY
2Adult Bone Marrow Transplant Service, Memorial, New York, NY
3Seres Therapeutics, Cambridge, MA
4Seres Therapeutics, Ipswich, MA
5Memorial Sloan Kettering Cancer Center,, New York,, NY
6University of Chicago Medical Center, Chicago, IL
7Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
8Massachusetts General Hospital / Harvard Medical School, Boston, MA

Aleksander L. Chojecki, MD1, Jai N. Patel, PharmD2*, David M Foureau, PhD3, James Symanowski, PhD4*, Xhevahire Begic, MSPH5*, Michael Davis, BS5*, Nury M Steuerwald, PhD6, Sarah Norek, BSN, RN5*, Srinivasa Reddy R. Sanikommu, MD1, Nilay A. Shah, MD1*, Brittany Knick Ragon, MD1, Thomas G. Knight, MD1, Jing Ai, MD, PhD1, Michael R. Grunwald, MD1, Nilanjan Ghosh, MD7, Lawrence J Druhan, PhD8, Belinda R. Avalos, MD1 and Edward A. Copelan, MD1

1Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
2Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC
3Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
4Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
5Clinical Trials, Levine Cancer Institute, Atrium Health, Charlotte, NC
6Levine Cancer Institute, Atrium Health, Charlotte, NC
7Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC
8Hematology Oncology Translational Research Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC

Gaurav Sutrave, BSc (Med), MBBS, FRACP, FRCPA1,2*, Tishya Indran, FRACP, FRCPA, MBBS3, Yatika Jivan, MBBS4*, Andrew Hutchison, FRACP, FRCPA5*, Nada Hamad, MBBS, BSc, MSc6, Sui Tan7*, Duncan Purtill8*, Andrew Grigg, MBBS, MD, FRACP, FRCPA9*, Siok-Keen Tey, MBBS, PhD, FRACP, FRCPA10,11, David J. Curtis, MBBS, PhD12, David J Gottlieb, MD, MBBS, FRACP, FRCPA13,14* and Abir Bhattacharyya, MBBS, FRACP, FRCPA13*

1Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia
2Department of Haematology, Westmead Hospital, Westmead, NSW, Australia
3Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, St Kilda East, Melbourne, VIC, Australia
4Department of Bone Marrow Transplantation, Royal Brisbane and Womens Hospital, Herston, Australia
5Blood Clinic, St John of God Healthcare, Murdoch, Australia
6Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
7St. Vincent's Hospital, Sydney, Australia
8Royal Perth Hospital, Shenton Park, Australia
9Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia
10Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Australia
11QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
12Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital, Melbourne, VIC, Australia
13Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, NSW, Australia
14Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia

*signifies non-member of ASH